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Abstract We have cloned a cDNA that encodes a novel 
Xenopus laevis oocyte adenylyl cyclase (xlAC) using oligonu-
cleotides against conserved mammalian adenylyl cyclase regions. 
The isolated cDNA is 4372 bp long with an open reading frame 
of 4065 nucleotides which encodes a protein of 1355 amino acids. 
Comparison of the deduced amino acid sequence with previously 
cloned mammalian adenylyl cyclases shows a low identity, 19.7% 
with type 2 rat adenylyl cyclase and 24.2% with type 4 rat 
adenylyl cyclase, indicating that this Xenopus isoform represents 
a new member of this protein family. Gene expression studies of 
the xlAC by reverse PCR showed that this gene is expressed in 
all oogenesis stages but not during early embryogenesis. 
Expression of the xlAC in COS-7 cells resulted in increased 
basal AC activity, that was stimulated by forskolin, Gpp(NH)p 
and aluminium fluoride, and was insensitive to calcium and 
calcium-calmodulin (Ca2 +-CaM). 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
In eukaryotic cells, adenylyl cyclase (AC) is a widely dis-
tributed effector system regulated by G-protein coupled recep-
tors (GPCR) which regulates the synthesis and levels of the 
second messenger cAMP. To date, eight different mammalian 
isoforms have been cloned and characterized from different 
sources [1-3]. All isoforms are stimulated by G a s and forsko-
lin but they differ in their tissue distribution and regulatory 
properties. Almost all AC, with the exception of type 4, are 
regulated directly or indirectly by Ca 2 + . Types 1, 3 and 8 are 
activated by Ca2 +-calmodulin, type 5 and 6 are inhibited by 
Ca 2 + levels and types 2 and 5 are activated by protein kinase 
C (PKC). Gpty dimers also modulate the activity of some A C 
isoforms, activating A C types 2 and 4 and inhibiting type 1 
[4,5]. 
All known mammalian A C isozymes share a predicted 
topological structure, designated as N M i C i M 2 C 2 , containing 
a short amino-terminal region (N) and two highly hydropho-
bic domains (Mi and M 2 ) that are postulated to contain six 
t ransmembrane helixes and two cytoplasmic domains (Ci and 
c2). 
In previous studies, we and other groups have biochemi-
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cally characterized an A C activity present in the Xenopus oo-
cyte plasma membrane and showed that this enzyme is acti-
vated by Gpp(NH)p , GTP-yS, cholera toxin (CTX) and 
forskolin but is insensitive to Ca2 +-calmodulin [6-10]. Intra-
cellular c A M P levels play an important role in the oocyte 
maturat ion process since inhibition of A C induces maturat ion 
[7] and substances that stimulate the enzyme block it [6,8]. In 
order to characterize this enzyme at the molecular level, we 
have cloned a full-length c D N A encoding a novel member of 
the AC family and expressed the protein in COS-7 cells. 
2. Materials and methods 
2.1. Isolation and sequencing of the xlAC cDNA 
A 276 bp AC fragment was amplified by PCR using oligonucleotide 
primers based on conserved regions present in all mammalian AC 
[11]. The sense primer was 5'-AGATCAAGACAATCGGATCTA-
CATACATGGC-3' which corresponds to the amino acid sequence 
KIKTIGSTYMA and the antisense primer was 5'-CATACGA-
GAAGCCACGTTCACTGTGTTTCCCCA-3' which encodes the 
amino acid sequence WGNTVNVAASRM. Phage DNA (100 ng), 
prepared from a ^.gtlO stage VI oocyte cDNA library [12], was sub-
jected to amplification in 50 u.1 reactions containing lXpolymerase 
buffer; 1.5 mM MgCl2; 200 uM of each dNTP; 400 nM of each 
primer and 2.5 units of Taq DNA polymerase (Promega Corp.). 
The reaction mixtures were incubated at 94°C for 5 min and then 
cycled 35 times for 1 min at 95°C, 1 min at 48°C and 1.5 min at 
72°C, followed by a final incubation of 10 min at 72°C. The PCR 
amplified fragment was subcloned into the pGEM 3zf- vector (Pro-
mega Corp.) and sequenced by the chain termination method using 
[cc-32S]dATP and Sequenase version 2.0 (US Biochemical). The se-
quenced PCR product was then labelled by random priming, using 
[a-32P]dATP and used to probe the xlAC cDNA library. Phages 
(5X105) were screened as described by Abramowitz et al. [13] and 
two positive phages were obtained, xlAC-a and xlAC-b. These clones 
were further purified through 3 rounds of consecutive screening. The 
cDNA inserts were excised with EcoRI, subcloned in the vector 
pTZ18R (Pharmacia) and sequenced as described above using succes-
sive oligonucleotides. Since the two isolated clones were truncated at 
their 5' end, another 300 bp fragment, corresponding to the 5' end of 
clone xlAC-b, was amplified and labelled to rescreen the library. 
1 X 106 phages were analyzed, from which four positive clones were 
obtained. Again, the phages were further purified and the cDNAs 
subcloned and sequenced as described above. 
2.2. Sequence comparison analysis 
Data analysis software CLUSTAL [14] was used to compare mam-
malian and Xenopus cloned AC. Mammalian AC sequences were ob-
tained from the Gene EMBL database. 
2.3. Reverse PCR 
Total RNA was prepared from isolated oocytes stages I to VI and 
from morula and blastula embryonic stages using guanidinium thio-
cyanate as described by Chomczynski and Sacchi [15]. Total RNA 
(1 ug) was reverse transcribed with the antisense primer 5'-TCAGA-
CATTATGAAAAGATG-3' (cDNA position 1318) according to 
Onate et al. [16]. A 20 ul volume of the reverse transcription reaction 
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MEIQVTGVSGQARSCQNPSVCLKFTAGGVSRGGGGELVGGKVPDKLYINNMASPWQQLL 60 
HHTEVRCDGSGDGSSVTVRINRQHHQAPSRRCKYSISSSCSSGESGVKKTGGSGGARRQK 120 
KLPOLFERSTSNWWNPKFDSNNLEEACVERCFPOTORRFRYALMYLSVAGLLWSIYFSVH 180 
MKTKLVSHLVPTLCFLIVCLGFFFFTFTKSYARRHCTAISLLVTLLVFTLTIASOFOVLN 240 
GLGSDSLSNLTSFSATGSSSCLSOVGSFSICVEVLLLLYTVMHLPLYLSACLGVAYSILF 300 
E TFGYHFRDE SCFVLLVGRMAHWELLSKALLHVCIHAIGVHLFIMSEVRSRSTFLKVGQS 360 
IMHGKDLEVEKALKERMIHSVMPRIIADDLMKQGDDESENSVKRHSASSPKSRKKKSSIQ 420 
KTPIIFRPFKMQRIEQVSILFADIVGFTKMSANKSAHALVGLLNDLFGRFDRLCEETKCE 480 
KISTLGDCYYCVAGCPEPRPDHAYCCIEMGLGMIEAIDQFCQEKKEMVNMRVGVHTGTVL 540 
CGILGMRRFKFDVWSMDVNLANLMEQLGVAGKVHISEKTARYLDDRYLMEDSMVVERLGQ 600 
IVAADQLKGLKTFLISGGRTRVPSCSCSQTL1PVQEGTDLSSPSLAPHVQAAISETSDSH 660 
TNCTQPETLKSCPSCGETAARDGPEEGVSAANGGGEEWKGGAPRPSAIGASLKDPERSPE 720 
SSTGDTLTNSQASLYDMLQEKGRWCGVSMDQSALLPLRFKNIREKTDAHFVEVIKEDS1M 780 
KDYFFKPPINPLSLNFLDKELETSYRASYOEEVIRMAPVKTFASATFSSLODVLLNYFIF 840 
VLLSVACLLKPGTNTVSPPTLALVLLSVCGLLGFLSLLVSVRMAFYLEDMLLCTRRLLEI 900 
ISGWVPRHFIGTVLVCLPAAVIFSYLSSDFYTDIHYTMFLCSALLIPMVOYCNFCOLSSS 960 
ALLLATITGATMLILIYLPLCPORPPLDPGTDIEANLSTSNSSYETLDNPRIELPFTRLG 1020 
OEIAVAYFLLLLLVWFLNREFDVSYRLHYHGDVEADLHRTKIOSMRDOADWLLRNIIPYH 1080 
VAEQLKVSQSYSKNHDDAGV1FASIVNFSEFYEENYEGGKECYRALNELIGDFDELLSKP 1140 
HYSCJEKIKTIGATYM^ASGLNPSQCQDSSQPHRHLQTLFEFAKEMMSWDEFNNNMLWF 1200 
NFKLRIGFNHGPLTAGVIGTTKLljYDIWGDTVNIASRl»tDTTGVECRIQASEESYRVLVKM 1260 
GYDFDYRGTVNVKGKGQMKTYHFPKCTDNGGLVPHHQLCISPDIRVQVDGSIGRSPTDEI 1320 
SSLVTGGKGAVELGSGEAERKREKAEERGRDGGAR 1355 
Fig. 1. Deduced amino acid sequence of the Xenopus laevis oocyte cDNA clone. Sequences, predicted as transmembrane regions, are underlined 
and empty boxes indicate the two amino acid conserved regions present in all mammalian adenylyl cyclases. Numbers on the right indicate the 
amino acid position along the sequence. 
was mixed with 80 ul of a PCR master mixture containing the sense 
primer 5-TGTGGAGCATCTACTTTAGT-3' (cDNA position 812) 
and the rest of the PCR mixture components [16]. Aliquots of 10 ul 
of the PCR reaction were subjected to electrophoresis on 2% Nusieve-
1% agarose gels in the presence of ethidium bromide. 
2.4. Adenylyl cyclase expression in COS-7 cells 
The reconstructed full-length xlAC cDNA was subcloned into the 
pCEV29 vector to give the recombinant vector pCEV29/xlAC. COS-7 
cells were grown to 80% confluence in Dulbecco's modified Eagle's 
medium (DMEM) supplemented with inactivated 10% fetal calf se-
rum, 100 IU/ml penicillin and 100 ug/ml streptomycin in a humidified 
incubator containing 5% CO2 at 37°C. Transfections were performed 
using 5 (ig of plasmidial supercoiled DNA by the DEAE-dextran 
method, including chloroquine treatment. After 2 days, cells were 
scraped in lysis buffer (25 mM Tris-HCl, pH 7.5; 1 mM EDTA, 
1 mM DTT; 0.1 mg/ml leupeptin and 1 mM PMSF) and homogen-
ized by passing the cells 10 times through a 23-gauge needle. Cell 
lysates were immediately assayed for AC activity. 
2.5. Adenylyl cyclase assay 
AC activity was measured at 32°C in a buffer containing 25 mM 
Tris-HCl pH 7.5, 1 mM 3-methylisobutylxanthine (IBMX), 5 mM 
MgCl2, 1 mM EDTA, 20 mM creatine phosphate, 250 |xg/ml creatine 
phosphokinase, 30 ug/ml myokinase, 1 mM cold cAMP, 1 X 104 cpm 
[3H]cAMP, 0.1 mM ATP and 5X106 cpm [a-32P]ATP. The reaction 
was started by the addition of 20 ug of cell lysate to a final volume of 
50 ul. All points were assayed in triplicate and cAMP accumulation 
was determined by Dowex and alumina chromatography as described 
by Birnbaumer et al. [17]. Protein concentration was measured by the 
method of Lowry et al. [18]. 
3. Results 
3.1. Cloning of a cDNA encoding a complete open reading 
frame (ORF) of a Xenopus laevis oocyte adenylyl cyclase 
A 4372 bp c D N A fragment encoding the complete amino 
acid sequence for an X. laevis oocyte adenylyl cyclase was 
isolated from a stage VI Xenopus oocyte c D N A library. The 
first screening gave two positive clones, xlAC-a and xlAC-b, 
that were truncated at the 5' end region (NH2- terminal) . In 
order to clone the complete cDNA, a second screening was 
performed using a P C R probe corresponding to the 5' end 
region of clone xlAC-b. Four positives clones were obtained 
and the largest one, clone xlAC-d (3200 bp) was truncated at 
its 3 ' end but overlapped with clone xlAC-b by 1042 bp. The 
overlapping region contained a BamRl site which was used to 
generate the complete c D N A from clones xlAC-b and xlAC-d. 
The resulting sequence was 4372 bp long with a putative ini-
tiation codon at position 300 and a stop codon at position 
Fig. 2. Reverse PCR detection of xlAC mRNA from different oo-
cyte stages and early embryogenesis. 1 u.g of total RNA from oo-
cyte stages I to VI and from morula and blastula were subjected to 
reverse PCR amplification with the specific pair of primers indicated 
in Section 2. PCR products were analyzed by agarose gel electro-
phoresis and ethidium bromide staining. The arrow indicates the 
size of the xlAC product (526 base pair). Lanes: 1, negative control 
without RNA; 2, negative control without RNA and the sense pri-
mer; 3, negative control without the sense primer; 4, oocyte stages 
I and II RNA; 5, oocyte stage III RNA; 6, oocyte stage IV RNA; 
7, oocyte stage V RNA; 8, oocyte stage VI RNA; 9, blastomer 
RNA; 10, morula RNA; 11, blastula RNA. 
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4364. No polyadenylation signal and no poly-A tail were 
found at its 3' end. 
3.2. Analysis of the xlAC predicted amino acid sequence 
The cloned cDNA has an open reading frame that encodes 
a protein of 1355 amino acids with a calculated molecular 
mass of 150 kDa (Fig. 1). Hydropathy analysis of the xlAC 
predicted amino acid sequence showed the presence of 12 
transmembrane spanning regions (data not shown), a charac-
teristic feature for all adenylyl cyclases (Fig. 1, underlined 
sequences). Alignment of the xlAC protein sequence with oth-
er known mammalian species showed in general, a low iden-
tity (24% with bovine type 1; 23% with rat type 2; 20% with 
rat type 3; 22% with rat type 4; 19% with mouse type 5; 21% 
with rat type 6 and 22% with rat type 8 adenylyl cyclases). 
Recently, a mouse type 9 adenylyl cyclase has been reported 
[19,20] which is more similar to the xlAC (70% of identity), 
and the dendrogram obtained from this alignment clearly 
shows that these two isoforms represent a new group of this 
protein family (data not shown). 
3.3. Detection of xlAC mRNA during oogenesis and early 
embryogenesis by the reverse PCR reaction 
Expression of xlAC mRNA was examined by reverse PCR 
using specific xlAC antisense primers and total RNA from 
oocyte stages I to VI and from morula and blastula embry-
onic stages. A 526 bp gene fragment was amplified in all 
oocyte stages but not in early embryonic stages (Fig. 2). 
The decreasing amount of xlAC mRNA observed through 
stages I to VI is due to the increase in the total RNA mass 
per oocyte. 
3.4. xlAC expression in COS-7 cells 
In order to determine whether the xlAC cDNA indeed en-
coded a functionally and active enzyme, COS-7 cells were 
transfected with the pCEV29/xlAC vector and AC activity 
was measured. Fig. 3 demonstrates the kinetics of basal and 
forskolin AC activation of transfected COS-7 cell lysates. The 
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Fig. 3. Kinetics of cAMP accumulation. Lysate fractions from 
COS-7 cells transfected with the plasmid pCEV29 alone (D,A) and 
with the construction pCEV29/xlAC (■,•) were incubated in the ab-
sence (□,■) or presence ( A , » ) of 100 uM forskolin. 50 JJ.1 aliquots 
(20 |ig of protein) were taken at the indicated times and cAMP pro-
duction was determined as described in Section 2. 
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Fig. 4. Induction of cAMP levels by known AC effector molecules. 
20 ug of crude lysate from COS-7 cells transfected with the plasmid 
vector pCEV29 alone, with xlAC or with rat AC6, were incubated 
with 100 uM forskolin, 20 |i,M Gpp(NH)p and 1 mM NaF for 30 
min and cAMP production was determined as described in Section 
2. The data shown are the mean ± S.D. of three experiments. 
basal activity was about 3-times higher in cells transfected 
with the pCEV29/xlAC vector when compared to those trans-
fected with the vector alone, and this difference was even more 
dramatic when 100 u,M forskolin was used. To study the 
regulatory properties of the xlAC, enzymatic activity was de-
termined in the presence of different effectors. As shown in 
Fig. 4, basal activity of xlAC transfected COS-7 cells was 
stimulated 4.7-, 3.3- and 2-fold by 100 uM forskolin, 20 uM 
Gpp(NH)p and 1 mM NaF, respectively. As a control, we 
transfected cells with rat AC6, which showed a similar re-
sponse, but the level of stimulation with the different activa-
tors was lower. After proving that the xlAC was active and 
responded to the different effectors, we studied the role of 
Ca2+ in the regulation of xlAC activity. As shown in Fig. 5, 
no effect on xlAC and mouse AC9 was seen on addition of 
1 mM EGTA, 1 uM Ca2+ or 1 uM calmodulin plus 1 uM 
Ca2+. In contrast, rat AC8 was inhibited by EGTA and 
stimulated by Ca2+ and Ca2+/calmodulin as has been 
described by Seamon and Daly [21]. 
4. Discussion 
In the present study we cloned the xlAC using two primers 
against two highly conserved regions present in the second 
cytoplasmic loop of all mammalian AC [11]. Subsequently, 
these primers were used to amplify a DNA fragment to screen 
the Xenopus laevis cDNA library. After two consecutive 
screenings it was possible to isolate two truncated clones 
that overlapped by a region of more than 1000 bp which 
contained a single BamHI restriction site that was used to 
construct the full-length xlAC gene. By analyzing the deduced 
amino acid sequence, we concluded that the ATG localized at 
position 300 within the sequence GCATGGAG, that is sim-
ilar to the Kozak consensus sequence, is the putative trans-
lation initiation codon. Although this 5' region has a rela-
tively low GC content ( < 50%>), it contains seven stops 
codons that are upstream of the ATG mentioned above. 
The open reading frame, which starts at this point, is 4065 
bases long and encodes a protein containing 1355 amino 
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Fig. 5. Effect of Ca2+ and calmodulin on xlAC, mouse AC9 (mAC9) and mouse AC8 (mAC8). 20 ug of the crude lysate fraction from non-
transfected COS-7 cells and from cells transfected with the vector pCEV29 alone, xlAC, mAC9 and mAC8 were incubated with Ca2+ and Ca2+ 
plus calmodulin in the presence or absence of EGTA for 30 min and cAMP production was determined as described in Section 2. The data 
shown are the mean ± S.D. of three experiments. 
acids. Hydropathy analysis showed that this protein shares 
the same topological distribution of all mammalian ACs 
and also contains the two highly conserved sequences E K I K -
T I G A T Y M A and Y D I W G D T V N I A S R M . The large diver-
gence observed between xlAC and other mammalian ACs in-
dicates that, together with rat type 9 AC, they belong to a new 
group within this protein family. 
Detection of xlAC m R N A during oogenesis agrees very 
well with previous studies that biochemically characterized 
this activity in the Xenopus oocytes [22]. The oocyte A C ac-
tivity shares the same regulatory properties with the protein 
encoded by the xlAC gene characterized in this work, since it 
is activated by forskolin, Gpp(NH)p , aluminium fluoride and 
insensitive to Ca 2 + and Ca2 + /calmodulin. 
In X. laevis oocytes, progesterone induces maturat ion 
through a still unidentified membrane receptor, and its first 
effect is to inhibit A C which causes a decrease in intracellular 
c A M P levels [20]. For this reason it is important to continue 
characterizing this xlAC to understand its physiological role 
in the maturat ion process. 
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